Borealis was founded on the principle that great ideas and entrepreneurial talent existed in northern New England, but that access to early stage capital and experienced mentorship was lacking. We believe that this is still true. In 2012, Borealis began to deploy the Borealis Granite Fund, a pool of capital intended to nurture emerging technology companies in New Hampshire and to set the stage for their growth.
Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that 12 new partner programs entered clinical development in 2018. This brings the total number of [...]
Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced the closing of the final $49 million of its $132 million Series A financing. This financing [...]
Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that in 2017 it entered into agreements with seven new companies. In addition, Adimab announced the [...]
Eli Lilly likes what it sees in Adimab's antibody R&D platform, opting to roll it out at sites in San Diego and New York to help its antibody discovery and optimization activities. The big pharma [...]
"The New Hampshire Charitable Foundation is dedicated to connecting its donors with effective organizations and ideas, but also to ensuring that the assets with which it is entrusted are maximized. Our partners at Borealis map tightly to each of those dimensions of our mission: they are effective stewards of our assets, but also share our commitment to improving the communities that comprise the state."
New Hampshire Charitable Foundation
We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.